Use access key #2 to skip to page content.
$80.62 -6.91 (-7.89%)
10/6/2008 4:00 PM

Genentech, Inc. (DNA)

CAPS Rating:
****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

View All Commentary (DNA)

Recs

6

Avatar bbobNJ (87.21) Submitted: 8/25/06 4:41 AM : Outperform Start Price: $79.70 DNA Score: 20.33

Genentech has been moving sideways for a year, and it may do the same throughout 2007, but at the rate earnings are increasing this stock will eventually rise. The science at Genentech is very very well funded and will continue to lead the industry.

Report this Post Replies: 0 | Reply

Featured Broker Partners